title: SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price.
authors.affiliation: Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Department of Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada; ernesto.schiffrin@mcgill.ca.
authors.forename: Ernesto L
authors.initials: EL
authors.lastname: Schiffrin
authors.affiliation: Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, USA;
authors.forename: David A
authors.initials: DA
authors.lastname: Calhoun
authors.affiliation: Division of General Medicine, Hypertension Section, Department of Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Flack
mesh_terms: D000368:Aged; D003920:Diabetes Mellitus; D019468:Disease Management; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D008875:Middle Aged; D010506:Periodicals as Topic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012955:Societies, Medical